Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Calron Z
- Development stage
- Unknown
- Lead developer
- East India Pharmaceutical Works
- Modality
- Small Molecules
- Administration
- Oral
01
Overview
Calron Z is a multivitamin and multimineral oral liquid formulation developed by East India Pharmaceutical Works. It is formulated with calcium gluconate, calcium lactate, zinc, ferrous ammonium citrate, and vitamin A. The supplement is designed to support bone health, boost immune function, aid in the management of iron deficiency anemia, and promote overall growth and development. It is typically administered orally as a syrup.
- Brand names
- CALRON-ZCalron Z
- Other names
- calcium gluconate + calcium lactate + ferrous ammonium citrate + vitamin A + zincmultivitamin and multimineral oral liquid
02
Targets
RARA (Retinoic acid receptor alpha)
Beyond the preview
Go deeper on Calron Z.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Calron Z.